Target 2035 - an update on private sector contributions.

Area of Science:

• Biomedical Science
• Pharmacology
• Drug Discovery

Background:

• Target 2035 is an international federation developing pharmacological tools for every human protein.
• These tools serve as crucial reagents for studying human health and disease.
• The initiative operates on 'open' principles, fostering collaboration.

Discussion:

• Pharmaceutical companies are increasingly joining Target 2035.
• Industry partners contribute valuable knowledge and reagents for novel protein research.
• This collaboration accelerates the development of essential scientific tools.

Key Insights:

• Open science principles are driving the creation of comprehensive protein-targeting tools.
• Industry-academia partnerships are vital for advancing drug discovery.
• Progress updates highlight the growing momentum and contributions to Target 2035.

Outlook:

• Continued expansion of pharmacological tools for all human proteins.
• Accelerated development of novel therapeutics for various diseases.
• Strengthened global collaboration in biomedical research.